 |
인쇄하기
취소
|
Vaccines make Green Cross No. 4 drugmaker
Green Cross became the fourth-biggest drug manufacturer in Korea in terms of quarterly revenue, as the outbreak of Influenza A boosted overseas demand for seasonal flu vaccines.
Green Cross posted revenues of 160 billion won in the second quarter, while Dong-A Pharmaceutical topped sales with 221.3 billion won.
Green Gross ranked fifth in terms of annual sales for the past five years, b...
Green Cross posted revenues of 160 billion won in the second quarter, while Dong-A Pharmaceutical topped sales with 221.3 billion won.
Green Gross ranked fifth in terms of annual sales for the past five years, b...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.